The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of treatment patterns and prognosis in correlation with age in patients with vulvar cancer: A subset analysis of the AGO-CaRE-1 study.
 
Katharina Prieske
Other Relationship - Medac
 
Linn Lena Woelber
Honoraria - Medac; Medac; MSD Oncology; Pfizer; Promedior; Roche; Tesaro; Teva
Consulting or Advisory Role - Genmab; Roche Molecular Diagnostics; Tesaro
Research Funding - Medac (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Medac; Tesaro
 
Mustafa Zelal Muallem
Honoraria - AstraZeneca; Ethicon; Olympus
Consulting or Advisory Role - Stryker
Travel, Accommodations, Expenses - AstraZeneca; Ethicon; Olympus; Roche
 
Christine Eulenburg
No Relationships to Disclose
 
Julia Kathrin Jueckstock
No Relationships to Disclose
 
Felix Hilpert
No Relationships to Disclose
 
Nikolaus de Gregorio
Consulting or Advisory Role - AstraZeneca; Biocad; Clovis Oncology; Ingress; PharmaMar; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Severine Iborra
No Relationships to Disclose
 
Atanas Ignatov
No Relationships to Disclose
 
Peter Hillemanns
No Relationships to Disclose
 
Sophie Fuerst
No Relationships to Disclose
 
Hans-Georg Strauss
No Relationships to Disclose
 
Klaus Baumann
No Relationships to Disclose
 
Falk Thiel
No Relationships to Disclose
 
Alexander Mustea
No Relationships to Disclose
 
Werner Meier
No Relationships to Disclose
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Lilly; MSD Oncology; Roche; Sotio; Stryker; Tesaro; Zai Lab
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Genmab (Inst); Roche (Inst); Tesaro (Inst)
 
Pauline Wimberger
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novocure; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro